The PCA3/PRUNE2 duplex undergoes A-to-I editing at multiple sites by ADAR1, which leads to reduced levels of PRUNE2, increased PCA3 expression levels and, thereby, a subsequent increase in cancer cell proliferation, adhesion and migration [46]. The gene discussed is ADAR; the disease is cancer.